Chronic Myelogenous Leukemia: From Pathogenesis to Therapy
- 1 February 1999
- journal article
- review article
- Published by Mary Ann Liebert Inc in Journal of Hematotherapy
- Vol. 8 (1) , 3-13
- https://doi.org/10.1089/106161299320523
Abstract
No abstract availableThis publication has 134 references indexed in Scilit:
- Apoptosis and chemotherapy resistanceEuropean Journal Of Cancer, 1996
- Multi-UnitAnti-BCR-ABLRibozyme Therapy in Chronic Myelogenous LeukemiaLeukemia & Lymphoma, 1996
- BCR-ABL: An Anti-Apoptosis Gene in Chronic Myelogenous LeukemiaLeukemia & Lymphoma, 1995
- Persistence of dormant leukemic progenitors during interferon-induced remission in chronic myelogenous leukemia. Analysis by polymerase chain reaction of individual colonies.Journal of Clinical Investigation, 1994
- Inventing and improving ribozyme function: Rational design versus iterative selection methodsTrends in Biotechnology, 1994
- Interleukin-3: Structure and FunctionCancer Investigation, 1993
- The BCR gene encodes a novel serine/threonine kinase activity within a single exonCell, 1991
- BCR sequences essential for transformation by the BCR-ABL oncogene bind to the ABL SH2 regulatory domain in a non-phosphotyrosine-dependent mannerCell, 1991
- Mice homozygous for the ablm1 mutation show poor viability and depletion of selected B and T cell populationsCell, 1991
- Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogeneCell, 1991